| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 08/04/2011 | US20110189129 Hepatitis c virus inhibitors |
| 08/04/2011 | US20110189095 Crkl targeting peptides |
| 08/04/2011 | CA2787827A1 A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy |
| 08/04/2011 | CA2786333A1 Vaccinia virus mutants containing the major genomic deletions of mva |
| 08/03/2011 | EP2351835A1 Method for producing purified influenza virus antigen |
| 08/03/2011 | EP2351770A1 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 08/03/2011 | EP2351768A1 HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 08/03/2011 | EP2350271A1 Arginine inactivation of viruses |
| 08/03/2011 | EP2350270A2 Human ebola virus species and compositions and methods thereof |
| 08/03/2011 | EP2350269A1 Simian adenoviruses sadv-43, -45,-48,-49, and -50 and uses thereof |
| 08/03/2011 | EP2350268A1 Method for the production of adenoviral vectors |
| 08/03/2011 | EP2118292B1 Papillomavirus e2 polypeptide used for vaccination |
| 08/03/2011 | EP0784631B1 Method of producing a partial orf2 protein of hepatitis e virus |
| 08/03/2011 | CN102140698A Complementary deoxyribonucleic acid (cDNA) library of ear marginal tissues of small tailed han sheep and construction method thereof |
| 08/03/2011 | CN102140477A Method for producing viral vectors |
| 08/03/2011 | CN102140442A Recombinant lentivirus as well as preparation method and application thereof |
| 08/03/2011 | CN102140441A Bird flu vaccine by using attenuated vaccinia Tian Tan as vector |
| 08/02/2011 | US7989162 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 08/02/2011 | CA2370187C Treatment of neoplasms with viruses |
| 08/02/2011 | CA2370103C Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 07/28/2011 | WO2011090712A2 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions |
| 07/28/2011 | US20110183894 Antiviral activity of the protein scytovirin and methods of use |
| 07/28/2011 | US20110183375 Metal binding compounds and their use in cell culture medium compositions |
| 07/28/2011 | US20110182936 Influenza hemagglutinin and neuraminidase variants |
| 07/28/2011 | US20110182933 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182932 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182931 Immortal avian cell line and methods of use |
| 07/28/2011 | US20110182901 Full length large t tumor antigen of merkel cell polyomavirus as a therapeutic target in merkel cell carcinoma |
| 07/28/2011 | CA2785971A1 Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof |
| 07/27/2011 | EP2348119A2 Multicistronic lentiviral vector |
| 07/27/2011 | EP2346990A1 Live, attentuated respiratory syncytial virus |
| 07/27/2011 | EP1794329B1 Porcine reproductive and respiratory syndrome isolates and methods of use |
| 07/27/2011 | EP1278823B1 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 07/27/2011 | EP0904395B2 Herpes simplex virus strains |
| 07/27/2011 | CN102134609A Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 07/27/2011 | CN102134562A Construction and screening of rabies virus Evelyn-Rokitnicki-Abelseth (ERA) attenuated live vaccine candidate strain |
| 07/27/2011 | CN102133398A Method for industrially producing animal influenza vaccine by using bioreactor |
| 07/27/2011 | CN101693894B Avian influenza virus H5N1 pseudotype virus, process for preparation and special DNA fragment thereof |
| 07/27/2011 | CN101357227B Senile dementia recombinant adenovirus gene vaccine and preparation method thereof |
| 07/27/2011 | CN101352570B Diploid cell rabies vaccine and method for preparing purified rabies vaccine |
| 07/26/2011 | US7985841 Heterodimeric receptor libraries using phagemids |
| 07/26/2011 | US7985840 Polypeptide fusion comprising complementary determining regions for use as tool in immunotherapeutic and/or diagnostics; bioassay |
| 07/26/2011 | US7985573 bacteriophage-drug conjugates, where the bacteriophage displays on its coat a ligand that endows it with specificity towards target cells, used as high-capacity drug delivery systems |
| 07/21/2011 | WO2011087839A1 Vaccine to influenza a virus |
| 07/21/2011 | WO2011086509A1 Methods of producing adenovirus vectors and viral preparations generated thereby |
| 07/21/2011 | WO2011031489A3 Umbilical cord amniotic membrane products |
| 07/21/2011 | US20110177125 Hsv-1 and hsv-2 vaccines and methods of use thereof |
| 07/21/2011 | US20110177124 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/21/2011 | US20110177121 Immunogenic Influenza Composition |
| 07/21/2011 | US20110177118 Non-Simian Cells for Growth of Porcine Reproductive and Respiratory Syndrome (PRRS) Virus |
| 07/21/2011 | US20110177037 Solenopsis invicta Virus |
| 07/20/2011 | EP2345716A1 Recombinant influenza viruses for vaccines and gene therapy |
| 07/20/2011 | EP2344647A1 Hepatitis c virus expressing reporter tagged ns5a protein |
| 07/20/2011 | EP2344634A1 Methods for cultivating cells, propagating and purifying viruses |
| 07/20/2011 | EP2344233A1 Methods for reducing viral load of hepatitus c virus in hemodialysis patients |
| 07/20/2011 | EP1994156B1 Chimeric tymovirus-like particles |
| 07/20/2011 | EP1373477B1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 07/20/2011 | CN102131920A Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof |
| 07/20/2011 | CN102127525A Adaption method of influenza virus vaccine strains on Vero cells |
| 07/20/2011 | CN102127524A Method for proliferating avian influenza viruses in bioreactor with cell carrier |
| 07/20/2011 | CN101397572B Method for rescuing influenza virus and bidirectional transcription vector special therefor |
| 07/19/2011 | US7981671 Use of triplex structure DNA in transferring nucleotide sequences |
| 07/19/2011 | US7981669 Viral vectors |
| 07/19/2011 | US7981656 Pseudotyped retrovirus with modified ebola glycoprotein |
| 07/19/2011 | US7981434 Surface exposed immunoglobulin D-binding protein from Moraxella catarrhalis |
| 07/19/2011 | US7981429 Influenza hemagglutinin and neuraminidase variants |
| 07/19/2011 | US7981428 Flu vaccines and methods of use thereof |
| 07/19/2011 | CA2308584C Targeted liposome gene delivery |
| 07/14/2011 | WO2011085231A2 Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines |
| 07/14/2011 | WO2011058081A3 In vitro method of directing evolution of a target polynucleotide of interest |
| 07/14/2011 | US20110172406 Molecular structure of rhd negative |
| 07/14/2011 | US20110172290 Isoforms of eIF-5A: Senescence-induced eIF5A; Wounding-induced elF-5A; Growth elF-5A; and DHS |
| 07/14/2011 | US20110171720 Single-domain brain-targeting antibody fragments derived from llama antibodies |
| 07/14/2011 | US20110171262 Parvoviral capsid with incorporated gly-ala repeat region |
| 07/14/2011 | US20110171256 Viral strains derived from the vaccinia virus lister vacv-107 and uses thereof |
| 07/14/2011 | US20110171253 Novel astrovirus |
| 07/14/2011 | US20110171249 Chimeric chikungunya virus and uses thereof |
| 07/14/2011 | US20110171248 Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines |
| 07/14/2011 | CA2785226A1 Photo-inactivated viruses and systems and methods of using the same |
| 07/14/2011 | CA2784137A1 Assay for jc virus antibodies |
| 07/13/2011 | EP2343380A1 Immunoglobulin variable region cassette exchange |
| 07/13/2011 | EP2343084A1 Functional influenza virus-like particles (VLP) |
| 07/13/2011 | EP1904626B1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications |
| 07/13/2011 | CN1922309B A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/13/2011 | CN1818054B Method and apparatus for destroying cell or virus |
| 07/13/2011 | CN102120988A Recombinant porcine circovirus type 2 strain expressing V5 epitope tag and application thereof |
| 07/13/2011 | CN102120987A Construction of four different sub-genotypes of porcine circovirus type 2 molecular cloning strains and application thereof |
| 07/13/2011 | CN102120986A Cell culture method of rotavirus |
| 07/12/2011 | CA2524394C Novel benzodiazepine compounds, compositions and uses thereof |
| 07/12/2011 | CA2468957C Methods of propagation of influenza virus in cell lines over expressing sialyl transferases |
| 07/12/2011 | CA2448947C Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes |
| 07/07/2011 | WO2011082381A2 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
| 07/07/2011 | WO2011080505A2 Method of growing phage for commercial use |
| 07/07/2011 | US20110167507 Animal Model Having a Chimeric Human Liver and Suceptible to Human Hepatitis C Virus Infection |
| 07/07/2011 | US20110165683 Chimeric gammaretrovirus |
| 07/07/2011 | US20110165645 Methods Using Ion Exchange and Gel Filtration Chromatography for Poxvirus Purification |
| 07/07/2011 | US20110165629 Recombinase-Based Methods for Producing Expression Vectors and Compositions for Use in Practicing the Same |
| 07/07/2011 | US20110165553 Vitrified composition which preserves biological materials |
| 07/07/2011 | US20110165230 Attenuated live vaccines |
| 07/07/2011 | US20110165226 Influenza cap-leader sequence |